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Low birth weight, nephron number, and kidney disease. More
and more evidence is emerging that highlights the far-reaching
consequences of prenatal (intrauterine) programming on or-
gan function and adult disease. In humans, low birth weight
(LBW) occurs more frequently in disadvantaged communities
among whom there is often a disproportionately high incidence
of adult cardiovascular disease, hypertension, diabetes mellitus,
and kidney disease. Indeed, many epidemiologic studies have
found an inverse association between LBW and higher blood
pressures in infancy and childhood, and overt hypertension in
adulthood. Multiple animal models have demonstrated the as-
sociation of LBW with later hypertension, mediated, at least
in part, by an associated congenital nephron deficit. Although
no direct correlation has been shown between nephron number
and birth weight in humans with hypertension, nephron num-
bers were found to be lower in adults with essential hyperten-
sion, and glomeruli tend to be larger in humans of lower birth
weight. An increase in glomerular size is consistent with hyper-
filtration necessitated by a reduction in total filtration surface
area, which suggests a congenital nephron deficit. Hyperfiltra-
tion manifests clinically as microalbuminuria and accelerated
loss of renal function, the prevalence of which are higher among
adults who had been of LBW. A kidney with a reduced nephron
number has less renal reserve to adapt to dietary excesses or to
compensate for renal injury, as is highlighted in the setting of
renal transplantation, where smaller kidney to recipient body-
weight ratios are associated with poorer outcomes, independent
of immunologic factors. Both hypertension and diabetes are
leading causes of end-stage renal disease worldwide, and their
incidences are increasing, especially in underdeveloped com-
munities. Perinatal programming of these 2 diseases, as well
as of nephron number, may therefore have a synergistic im-
pact on the development of hypertension and kidney disease
in later life. Existing evidence suggests that birth weight should
be used as a surrogate marker for future risk of adult disease.
Although the ideal solution to minimize morbidity would be to
eradicate LBW, until this panacea is realized, it is imperative
to raise awareness of its prognostic implications and to focus
special attention toward early modification of risk factors for
cardiovascular and renal disease in individuals of LBW.
Resumen
Existen cada dı´a ma´s evidencias que documentan las conse-
cuencias a largo plazo de la programacio´n prenatal (intraute-
rina) de la funcio´n orga´nica y su relacio´n con la enfermedad
en el adulto. En humanos, el bajo peso al nacer (BPN) se pre-
senta con mayo frecuencia en poblaciones marginadas, en las
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cuales se observa tambie´n una incidencia desproporcionada-
mente mayor de enfermedad cardiovascular, hipertensio´n, dia-
betes mellitus y enfermedad renal. Efectivamente, muchos es-
tudios epidemiolo´gicos han reportado una asociacio´n inversa
entre el BPN y una presio´n arterial elevada en la infancia, ası´
como con hipertensio´n arterial en el adulto. Mu´ltiples modelos
en animales de experimentacio´n han demostrado la asociacio´n
entre el BPN y el desarrollo posterior de hipertensio´n, mediado
en parte por un de´ficit de nefronas al nacer. Aunque no se ha de-
mostrado en humanos hipertensos que exista una correlacio´n
directa entre el nu´mero de nefronas y el peso al nacer, si se
ha encontrado que en individuos con hipertensio´n esencial, el
nu´mero de nefronas se encuentra disminuido y los glome´rulos
tienden a ser ma´s grandes en personas con BPN. El aumento
en el taman˜o del glome´rulo es consistente con la hiperfiltracio´n
requerida para compensar la disminucio´n en el a´rea total de la
superficie de filtracio´n, sugiriendo un de´ficit conge´nito de ne-
fronas. La hiperfiltracio´n se manifiesta clı´nicamente mediante
la microalbuminuria y el deterioro acelerado de la funcio´n re-
nal; la prevalencia de ambos es mayor en individuos con BPN.
Un rin˜o´n con un nu´mero disminuido de nefronas, tiene una
reserva renal menor para adaptarse a excesos en la dieta o el
compensar el dan˜o renal, como se demuestra en el trasplante
renal, donde injertos pequen˜os en relacio´n al peso corporal del
receptor, se asocian a malos resultados, independientemente
de factores de tipo inmunolo´gico. Tanto la hipertensio´n como
la diabetes son las principales causas de insuficiencia renal a
nivel mundial y su incidencia ha aumentado, especialmente en
paı´ses en desarrollo. La programacio´n perinatal de estas dos
enfermedades, ası´ como del nu´mero de nefronas, pueden por
lo tanto tener un efecto sine´rgico en el desarrollo posterior de
hipertensio´n y enfermedad renal. Existen evidencias que sug-
ieren que el peso al nacer debe de ser utilizado como un mar-
cador de riesgo a futuro del desarrollo de enfermedad en la vida
adulta. Aunque la solucio´n ideal serı´a el erradicar el BPN, y en
tanto no se logre esta panacea, lo recomendable es alertar sobre
sus implicaciones pronosticas, poniendo especial atencio´n en la
modificacio´n temprana de los factores de riesgo de enfermedad
cardiovascular y renal en individuos con BPN.
Genetic factors are important determinants of de-
velopment and function of major organ systems, and
susceptibility to disease. Environmental factors are also
important. More and more evidence is emerging high-
lighting the far-reaching effects of prenatal (intrauterine)
programming on subsequent organ function and adult
disease. This review will outline the effects of fetal pro-
gramming on renal development (nephrogenesis) and the
risk of hypertension and kidney disease in later life.
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Low birth weight (LBW) is defined by the World
Health Organization as a birth weight of <2500 g. LBW
and intrauterine growth retardation (IUGR, below the
tenth decile for birth weight) occur more frequently in
disadvantaged communities and have been associated
with a subsequent disproportionately high incidence of
cardiovascular disease, hypertension, diabetes mellitus,
and kidney disease in these populations [1–4]. In the
United States, the incidence of LBW is twice as high
in the African American compared with the Caucasian
population [1, 5–7]. Risk factors for LBW and IUGR ap-
pear to be relatively consistent among different popula-
tions, including blacks, those of Asian origin, maternal
hypertension, maternal smoking, poor maternal weight
gain during pregnancy, shorter maternal height, poor an-
tenatal care, and lower socioeconomic status [1, 8–10].
However, maternal anthropometrics, health, age, and so-
cioeconomic status do not entirely explain the dispar-
ity in LBW among African American and Caucasian
American infants [6]. Factors intrinsic to black ethnic-
ity may therefore have an independent impact on birth
weight.
Fetal malnutrition and IUGR may result broadly from
maternal undernutrition and/or placental insufficiency.
Henriksen and Clausen have highlighted the importance
of distinguishing between these 2 causes of IUGR, be-
cause they are likely to have different impacts among
different populations [11]. Placental insufficiency re-
sults from poor placentation, usually associated with
preeclampsia and maternal cardiovascular risk factors.
This is likely to have a greater impact on LBW than
maternal diet in adequately nourished populations. In
poorer communities, however, maternal malnutrition is
more prevalent and is likely to have a significant inde-
pendent effect on fetal outcome in addition to placen-
tal insufficiency. Maternal malnutrition is complex, and
dietary composition may be more important than total
calorie intake in determining pregnancy outcomes, birth
weight, and subsequent disease. Moderate maternal un-
dernutrition periconception in sheep has been associated
with increased risk of preterm birth [12]. Langley-Evans
et al have demonstrated that even short periods of ma-
ternal protein restriction during gestation in rats are as-
sociated with LBW and subsequent hypertension [13–
15]. In humans, increased maternal lean body mass and
protein turnover at 18 weeks of gestation are associated
with increased length of babies at birth [16]. In an analy-
sis of the long-term effects of different dietary composi-
tions ingested during pregnancy, higher blood pressures
were seen at 40 years of age in offspring of mothers who
had had a high carbohydrate intake during pregnancy,
but whose animal protein intake had been under 50 g
daily [17]. Similar dietary composition is highly preva-
lent among poor communities. In another study, however,
ethnic differences in nutritional intake among pregnant
women were found not to account for the disparities in
LBW among nulliparous women from population groups
[5].
Maternal hypertension is a significant risk factor for
LBW and is more prevalent among black than white
women, making the population-attributable risk of LBW
highest among babies of hypertensive black mothers [1].
Furthermore, IUGR of the mother has been identified as
a risk factor for IUGR of her offspring [18]. It is tempt-
ing to speculate that the increase in maternal hyperten-
sion among black women may be part of a vicious cycle
resulting from maternal LBW, predisposing to hyperten-
sion, which in turn predisposes the offspring to LBW and
subsequent hypertension.
LBW AND THE KIDNEY
Multiple animal models have demonstrated the asso-
ciation of LBW (induced by gestational exposure to low
protein diet, dexamethasone, gentamicin, vitamin A de-
privation, or uterine ischemia) with later hypertension
[13, 19–24]. The link between adult hypertension and
LBW in these animal models appears to be mediated, at
least in part, by an associated congenital nephron deficit
occurring with IUGR [19, 21, 23]. Vehaskari et al demon-
strated an almost 30% reduction in glomerular number
in LBW rats as compared with those of normal birth
weight, and the LBW rats had systolic blood pressures
that were 20 to 25 mm Hg higher by 8 weeks of age
[21]. Similarly, Celsi et al found that prenatal admin-
istration of dexamethasone in rats was also associated
with LBW and fewer glomeruli compared with controls.
In these nephron-deficient rats, glomerular filtration rate
(GFR) was reduced, albuminuria was increased, urinary
sodium excretion was lower, and tissue sodium content
was higher [19]. Studies examining the effect of LBW on
the activity of the renin-angiotensin system have found
that renin and angiotensin activity and renal messenger
RNA levels are reduced in LBW animals, possibly con-
sistent with a degree of volume expansion secondary to
sodium retention [21, 22]. These findings in animals lend
credence to the hypothesis initially put forward by Bren-
ner et al that a congenital deficit in nephron number,
resulting in a decreased filtration surface area and thus a
limitation in renal sodium excretion, may be an indepen-
dent factor determining susceptibility to essential hyper-
tension in humans [25].
LBW AND HYPERTENSION IN HUMANS
Consistent with the animal data, many human stud-
ies have also revealed an inverse association between
LBW and higher blood pressures in infancy, childhood,
and adulthood. In children, most studies have reported
higher blood pressures in those who had been of LBW,
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an effect which remained significant after adjustment for
current weight [26–33]. In several studies, the relation-
ship was more significant in girls than boys [28, 31]. In
adolescents, the relationship between blood pressure and
birth weight is often lost [34, 35], but some studies do still
show an inverse relationship between birth weight and
present blood pressure [36–38]. In young adults, most
studies found blood pressures tend to be higher in those
who had been of LBW, even after correction for current
weight, smoking, oral contraceptive use, and gender [36,
39–42], although some studies failed to find a consistent
relationship [43]. The impact of parental blood pressure
was analyzed as a potential confounder of the relation-
ship between birth weight and current blood pressure,
and indeed correction for parental blood pressure did
decrease, but did not eliminate, the strength of the in-
verse association [44]. Barker et al first reported the as-
sociation between hypertension in adult life and birth
weight [45]. They found that mean systolic pressure fell by
11 mm Hg as birth weight increased from ≤5 lb to ≥7.5 lb
in 449 adults from 46 to 64 years of age. Subsequently,
other studies have found similar associations [46–55].
Again, in some studies the effect was more pronounced
in women [49, 51].
Taken together, many studies therefore suggest that
prenatal factors have an impact on blood pressure in
later life. However, reported blood pressures tend to be
higher in infants, children, and young adults of LBW
but do not reach overt hypertensive ranges until well
into adulthood in most studies. Blood pressure does ap-
pear to “track” throughout age groups, and children with
higher blood pressures become adults with higher blood
pressures [27, 46]. The relationship between birth weight
and blood pressure is also augmented by accelerated
postnatal growth [56]. The differences in blood pressure
between people of LBW and normal birth weight also be-
come amplified with age, with the result that adults who
had been of LBW develop overt hypertension, which in-
creases with age [33].
Studies in twins have attempted to separate out the
relative impact of genetic predisposition to higher blood
pressures from the impact of environmental influences.
Levine et al found that at 1 year, the twin of lower birth
weight had a more rapid rise in blood pressure during in-
fancy, and that greater differences in birth weight among
monozygotic twin pairs were associated with smaller dif-
ferences in blood pressure [57]. Another study of twin
pairs at age 18 to 34 years, using 24-hour ambulatory
blood pressure monitoring, also found higher blood pres-
sures in the lower-birth-weight twin but only among
women [58]. These data suggest that intrauterine envi-
ronmental factors that resulted in lower birth weight of
1 twin had an impact on that twin’s subsequent blood
pressure.
The kidney is the organ central to the development
of hypertension. The relationship between renal sodium
handling, intravascular-fluid-volume homeostasis, and
hypertension, initially described by Guyton, is well ac-
cepted [59, 60]. In addition, all known genetic mutations
associated with hypertension are mutations in proteins
expressed in the kidney [61]. That factors intrinsic to the
kidney itself affect blood pressure has been demonstrated
in renal transplantation, where blood pressure in the re-
cipient after transplantation has been shown to be related
to the blood pressure or hypertension risk factors of the
donor; that is, hypertension “follows” the kidney [62].
Conceivably, therefore, a congenital alteration in renal
sodium handling, as a result of a congenital reduction in
nephron number, is likely to have an impact on blood
pressure.
LBW AND NEPHRON NUMBER IN HUMANS
A recent study of kidneys of adult Caucasians who died
in accidents revealed that those with a history of essential
hypertension had significantly fewer glomeruli per kid-
ney, and greater glomerular volume than matched nor-
motensive controls [63]. Birth weights were not reported
in this study, but we suggest that a reduced nephron num-
ber is associated with susceptibility to hypertension.
In an attempt to determine whether IUGR is asso-
ciated with a reduction in nephron number, Hinchliffe
et al examined nephron number in stillbirths and infants
dying at 1 year of age who were born with appropriate
weight for gestational age (controls) or were small for ges-
tational age (IUGR) [64]. In both age groups, infants with
IUGR had fewer nephrons than controls. In addition, the
number of nephrons in control infants dying at 1 year
of age had not increased compared with stillbirths with
IUGR, which demonstrates the lack of postnatal com-
pensation in nephron number. Similarly, Manalich et al
examined the kidneys of neonates dying within 2 weeks of
birth in relation to their birth weights [65]. Significant in-
verse correlations were found between glomerular num-
ber and glomerular volume, and between birth weight
and glomerular volume, independent of sex and race
[65, 66].
Glomerulomegaly has also been found in renal biopsies
of Australian Aborigines, a population with highly preva-
lent renal disease and LBW, and has been associated with
a faster rate of decline of GFR in Pima Indians [67, 68]. In
the United States, a study comparing nephron numbers
between African Americans and Caucasians failed to find
a difference between races but did find a strong correla-
tion between birth weight and glomerular number, and
an inverse correlation between glomerular number and
glomerular volume [69]. Another study of donor kidneys
found maximal planar area of glomeruli to be higher in
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African Americans than Caucasians [70]. The correlation
of larger glomeruli with smaller nephron numbers sug-
gests that in the setting of a reduced nephron number,
the existing glomeruli must undergo compensatory hy-
pertrophy and hyperfiltration to sustain adequate renal
function, an adaptation that may hasten loss of existing
glomeruli and accelerate a decline in renal function.
It is known that as chronic renal failure progresses, re-
nal function is sustained by a decreasing number of func-
tioning nephrons, rather than by a constant number of
partially functioning nephrons. The increase in function
per surviving nephron is maintained by adaptive changes
in glomerular hemodynamics and intraglomerular pres-
sure leading to in an increase in single nephron (SN)
GFR [71]. Over time, however, the adaptive glomeru-
lar changes result in further loss of functioning nephrons
and continued renal functional decline. Such function-
ally adaptive, but physically detrimental, changes have
been demonstrated in animal models of renal mass abla-
tion, as well as of acquired chronic renal disease [71–76].
Loss of functioning renal mass becomes clinically mani-
fest with the development of systemic hypertension and
proteinuria, both of which accelerate ongoing renal in-
jury. Similar decline in renal function, with development
of hypertension and proteinuria, have been described in
animals born with reduced nephron numbers [77, 78] and
in humans with congenital deficiencies in renal mass [79–
82]. These observations support the hypothesis that ex-
trinsic renal injury is not a prerequisite for the initiation
and perpetuation of renal injury, and that under certain
circumstances, more subtle, prenatally derived, intrinsic
deficiencies in functioning renal mass may be sufficient
to contribute to renal functional decline in later life.
LBW AND KIDNEY DISEASE
In an animal model of LBW induced by maternal
low protein diet, with subsequent induction of diabetes,
Jones et al demonstrated that animals with LBW had re-
duced nephron numbers and that rats with LBW and di-
abetes had a greater proportional increase in renal size
and glomerular hypertrophy compared with normal birth
weight controls after 1 week of diabetes [83]. This study
demonstrates that renal response to injury in the setting
of a reduced nephron number may be exaggerated and
could lead to accelerated loss of renal function.
Compensatory adaptation to reduced nephron num-
bers results in an increased SNGFR and hyperfiltration.
Hyperfiltration may be clinically detected as microal-
buminuria. Studies from England, Russia, the United
States, and Australian Aborigines have demonstrated an
increased prevalence of microalbuminuria and protein-
uria among adults who had been of LBW [68, 84–88].
Among the Australian Aborigines, in whom the incidence
of end-stage renal disease (ESRD) is disproportionately
high, Hoy et al found that in addition to the association
of albuminuria with LBW, the degree of albuminuria pre-
dicted loss of renal function and was strongly correlated
with both renal and nonrenal deaths [68, 85, 87].
Other authors have examined the relationship between
birth weight and diabetic nephropathy and found an in-
creased susceptibility among patients with LBW [88–92].
Among women with insulin-dependent diabetes mellitus,
nephropathy was present in 75% of those with a birth
weight below the tenth percentile (≤2.7 kg), compared
with 35% in those with birth weights above the 90th per-
centile (≥4 kg) [91]. This relationship was not present in
men with insulin-dependent diabetes mellitus, but men
with diabetic nephropathy were significantly shorter than
those without nephropathy [90, 91]. Jacobsen et al at-
tempted to quantify the effect of birth weight on renal
disease progression in diabetic nephropathy using mea-
surements of GFR over a 3-year period [93]. This study
failed to find an association between birth weight and
progression of diabetic nephropathy, but the authors con-
cede that only 4% of their cohort had a birth weight under
2.5 kg, and many patients were receiving renoprotective
medications.
A handful of other reports have found a greater
severity of renal disease and more rapid progression of
immunoglobulin A, membranous and minimal change
nephropathies, and chronic pyelonephritis among adults
who had been of LBW [89, 92, 94–96]. Lackland et al ex-
amined birth weights in patients with ESRD in South
Carolina, where 70% of patients have ESRD due to
hypertension or diabetes, and the dialysis population is
younger than the national average [97]. They found that
the odds ratio for ESRD was 1.4 (1.1–1.8) among those
with birth weights under 2.5 kg compared with those of
normal birth weight. This association was consistent for
all causes or ESRD and was not affected by family history
of ESRD [97, 98].
LBW AND RISK FACTORS FOR KIDNEY
DISEASE: DIABETES MELLITUS
AND THE METABOLIC SYNDROME
Diabetes mellitus is the leading cause of ESRD world-
wide. Analogous to the studies of the association of LBW
with hypertension and nephron number, animal studies
have also demonstrated an association between LBW and
subsequent pancreatic insufficiency and diabetes mellitus
[99, 100]. Studies in humans have found similar associa-
tions [101–104]. For example, among men aged 64 years,
Hales et al reported an odds ratio for impaired glucose
tolerance or diabetes that decreased from 6.6 (1.5–28)
in those with a birth weight ≤5.5 lb to 1.4 (0.3–5.6) in
those with a birth weight ≥8.6 lb [102]. As evidence for
the effect of intrauterine environment on the develop-
ment of diabetes, among monozygotic twins, the twin with
diabetes was found to have a lower birth weight compared
with the genetically identical twin without diabetes [105].
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Subsequent studies have reported an increased preva-
lence of diabetes, in conjunction with the metabolic
syndrome (hypertension, hyperlipidemia, obesity, cardio-
vascular disease) in adults who had been of LBW [53,
106–113]. Analogous findings have been reported as early
as 8 years of age in children with LBW. In a cohort of
477 8-year-old Indian children, LBW was associated with
higher systolic pressure, higher total and LDL choles-
terol, and increased insulin resistance [114]. In most stud-
ies, it appears that children with LBW, or adults, who
have the highest current weights, that is, who “caught
up” fastest in weight, are those with the most signifi-
cant metabolic derangements [48, 110, 115]. One hypoth-
esis put forward to explain this association is the “thrifty
phenotype hypothesis,” which proposes that an under-
nourished fetus makes metabolic adaptations to reset the
insulin-hormonal axis [112, 113]. These adaptations have
short-term benefit by increasing fuel availability in utero
but may become maladaptive later in life under condi-
tions of adequate nutrition, manifesting as obesity and
insulin resistance.
FETAL PROGRAMMING OF KIDNEY
DISEASE RISK FACTORS IN
DISADVANTAGED POPULATIONS
Many of the studies mentioned above have emerged
from first-world countries, the United Kingdom, urban
Australia, Europe, Scandinavia, and the United States.
Very few studies have addressed the impact of fetal pro-
gramming of adult disease in disadvantaged populations,
and even in Western populations of African origin in
whom hypertension, diabetes, and renal disease are dis-
proportionately prevalent and LBW is common.
It has been proposed that LBW may be a component
factor participating in the increased risk of hypertension,
diabetes, and ESRD seen in the African American pop-
ulation compared with the white population [4]. In the
Unites States, the prevalence of LBW is up to 2-fold
higher among African Americans than among whites and
Hispanics [1, 6, 116]. African American men, especially
those from the South, have the highest blood pressures
compared with other race-sex groups [117]. The South-
ern black population has the highest incidence of LBW in
the country, independent of socioeconomic factors [116].
Black-white differences in blood pressure are also evi-
dent in children. In South African 5-year-olds, both sys-
tolic and diastolic blood pressures were highest in black
children compared with those in whites or children of
mixed race [117]. Black children in South Africa have
lower birth weights [117].
Law and Shiell, after conducting a systematic review of
the literature in 1996, highlighted the fact that only 4 of 32
reports had studied the association of LBW with blood
pressure in nonwhite patients [118, 119]. In an attempt
to address this paucity of information, these authors ex-
amined the effects of birth weight on blood pressure in
children from 4 developing countries [118]. Among 3-
to 6-year-old children in China, Guatemala, and Chile, a
consistent, inverse relationship was seen between birth
weight and systolic blood pressure but not among those
from Nigeria. In this study, however, all children had
birth weights above 2.5 kg and therefore were not strictly
of LBW. Studies in children from Jamaica and Gambia
have found an association between poor maternal weight
gain in the third trimester of pregnancy and subsequent
increased blood pressure in the child [120, 121]. Poor
maternal weight gain in pregnancy is often associated
with LBW. Further studies from Jamaica, South Africa,
Zimbabwe, the Democratic Republic of Congo, and
Brazil have also reported increases in systolic blood pres-
sure in children and adolescents associated with LBW [29,
37, 40, 122–125]. In addition, greater weight gain in chil-
dren with LBW was also associated with higher blood
pressures in Jamaican children [40]. In these developing
countries, therefore, fetal programming of blood pressure
appears to occur in a similar manner to that in Western
populations. In these disadvantaged communities, how-
ever, where LBW is common, persistent undernutrition,
resulting in stunted growth in these populations, may also
have an exacerbating effect on blood pressure: in some
studies, short stature is associated with higher blood pres-
sures independent of birth weight [126, 127].
Insulin resistance and metabolic syndrome have also
been found to be associated with birth weight in dis-
advantaged populations. Glucose control, insulin levels,
and serum cholesterol were associated with LBW and
shortness at birth in Jamaican children [124, 128]. Again,
the highest insulin concentrations were found in those
children who had been shortest at birth but were heavi-
est at the time of study [128]. Similarly, among Nigerian
adults, an inverse correlation was found between adult
height (used as a surrogate for birth weight) and blood
glucose levels [129]. In South Africa, young, nonobese
adults who had been underweight for age at birth had a
higher prevalence of elevated fasting blood glucose levels,
glucose intolerance, and systolic and diastolic blood pres-
sures [130]. Plasma cortisol levels were found to be higher
and increased more in response to adrenocorticotropic
hormone stimulation in the LBW group compared with
the normal birth weight group. We suggest that prenatal
programming of the hypothalamic-pituitary-adrenal axis
may be a fundamental mechanism underlying the devel-
opment of metabolic syndrome in populations with LBW.
NEPHRON “DOSING” IN TRANSPLANTATION
Prescription of donor kidneys based on immunologic
compatibility is widely accepted. Prescription of kidneys
on the basis of physiologic capacity of the organ to meet
the needs of the recipient has, however, not been rou-
tinely considered [131]. Although 1-year renal allograft
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survival rates have improved significantly over the past 2
decades with improvements in immunosuppressive reg-
imens, long-term survival rates have not followed suit.
This fact serves to highlight the importance of antigen-
independent factors in the development of chronic allo-
graft dysfunction.
An early study of living related renal transplant donors
and recipients pre- and post-donation and transplanta-
tion demonstrated that within the first month after trans-
plantation, the GFR in the allograft was invariably <50%
below that of the donor’s initial GFR [132]. In con-
trast, the donor’s GFR increased to 65% of the original
2-kidney value within 1 week of uninephrectomy, and
isograft GFRs (from identical twins) reached similar
levels within a month of transplantation. Furthermore,
although the allograft recipient GFRs increased progres-
sively over the first 6 months to levels similar to those
of the donor, biopsies after 2 to 4 years of transplanta-
tion revealed significant histologic abnormalities [132].
This study demonstrates the importance of immunologic
injury in early graft function but also highlights the fact
that despite comparable GFRs, the renal allograft devel-
ops progressive histologic injury.
Histologic features of chronic “rejection” resemble
those of native kidneys with chronic progressive kidney
disease; that is, the final common pathway of glomeru-
lar hypertension and hyperfiltration resulting from loss
of functioning nephron mass [133]. Indeed, studies car-
ried out in various rat models of renal transplantation
have demonstrated the importance of nephron mass, in-
dependent of immunologic factors, in the development
of chronic allograft nephropathy [134–138]. Significant
proteinuria and glomerulosclerosis develop in bilater-
ally nephrectomized rats receiving a single renal allo-
graft, whereas rats receiving 2 allografts or having a
single allograft in addition to a retained normal native
kidney showed much less renal injury in the allograft
[135]. Micropuncture data revealed glomerular hyperfil-
tration with marked internephron variation in the soli-
tary allografts compared with the 2-kidney groups [137].
In addition, patterns of cell surface molecule expression
in allografts were modulated by renal mass, demonstrat-
ing an additional impact on the “inflammatory” milieu
[134]. All of these observations beg the question: how
many nephrons are enough to avert ongoing renal injury
after transplantation?
Demographic and anthropomorphic factors associated
with late allograft loss include donor age, sex, and race, as
well as recipient body surface area (BSA) [139–141]. In-
directly, these observations suggest that nephron number
in the transplanted kidney may play a role in chronic allo-
graft failure, because kidneys from older, female African
American donors fare worse and tend to have lower
nephron numbers than those from younger Caucasian
male donors [70, 142, 143]. In addition, mismatch be-
tween donor kidney size and recipient BSA (proportional
to metabolic demand) has also been associated with al-
lograft outcomes. In a retrospective analysis of 32,083
patients receiving a first cadaver kidney, large recipients
of kidneys from small donors had a 43% increased risk
of late graft failure compared with medium-sized recipi-
ents receiving kidneys from medium-sized donors [144].
In contrast, another study of paired recipients of cadaver
kidneys from a single donor, where within each pair recip-
ients were stratified as “higher” or “lower” BSA, failed
to find a significant association between allograft failure
and recipient BSA [145]. However, the BSA ranges in the
“higher” and “lower” groups overlapped in this study.
Use of donor and recipient BSA may not necessar-
ily be the best method of estimating kidney to recipient
mismatch, because kidney size may not always be directly
proportional to BSA. Kidney weight is an acceptable sur-
rogate for nephron mass [133]. Kim et al analyzed the
ratio of donor kidney weight to recipient body weight in
259 live donor transplants [146]. They found that a higher
kidney weight to body weight ratio of>4.5 g/kg was signif-
icantly associated with improved graft function at 3 years
follow-up compared with a ratio of <3.0 g/kg. A similar
study used renal ultrasonography to measure cadaveric
transplant kidney cross-sectional area in relation to re-
cipient body weight, to calculate a nephron dose index
[147]. We found that serum creatinine was significantly
lower in the first 5 years of transplantation in patients with
high nephron dose index compared with those with lower
values, with a trend toward better graft survival. In fur-
ther support of the impact of nephron mass on allograft
outcome, several studies reported transplantation of dual
suboptimal kidneys (e.g., kidneys from older donors with
reduced renal function) and found comparable outcomes
to single kidney recipients [148–151]. In these cases, trans-
plantation of greater than the usual nephron mass ap-
peared to compensate for the less than optimal nature of
the kidneys.
The concept of an intrinsic nephron dose required to
adequately meet the metabolic needs of a recipient, that
would minimize imposition of detrimental hyperfiltration
on the donor kidney, should be more widely considered.
Before transplantation, in addition to the essential im-
munologic matching of donor and recipient, physiologic
matching, taking into account donor kidney weight and
recipient weight or BSA, may help to reduce the bur-
den of chronic allograft failure, reduce the numbers of
transplant recipients reenlisting for transplantation, and
allow more people to benefit from the limited number of
available organs.
CONCLUSION
Epidemiologic evidence for fetal programming of adult
disease is now quite compelling. That not all studies
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consistently demonstrate this effect may highlight subtle
mechanistic differences at play in different populations.
The mechanisms responsible for the association between
LBW and hypertension and kidney disease in later life ap-
pear to reflect impaired nephrogenesis. The normal num-
ber of nephrons in humans varies widely [142, 152]. A
kidney with a reduced complement of nephrons would
have less renal reserve to adapt to dietary excesses or to
compensate for renal injury. As evidence of this, it is be-
coming clear that donor kidney size, relative to recipient
size, is associated with long-term renal allograft function.
A small kidney transplanted into a large recipient may
not have adequate capacity to meet the metabolic needs
of the recipient, and thus would be subject to ongoing
glomerular hyperfiltration and renal injury.
Both hypertension and diabetes are leading causes
of ESRD worldwide, and their incidences are increas-
ing. Perinatal programming of these 2 diseases, superim-
posed on a concomitant reduction in nephron number,
may therefore have significant impact on the develop-
ment of hypertension and kidney disease in later life.
LBW is highly prevalent in disadvantaged communities,
and is likely to be a significant, but thus far underappre-
ciated, contributor to the increasing prevalence of hy-
pertension, diabetes, and ESRD worldwide. Specifically,
among transitional communities where LBW is preva-
lent, but subsequent diets are associated with the devel-
opment of childhood and adult obesity, the impact of fetal
programming on future adult disease is of great potential
to public health importance. Present evidence suggests
that birth weight should be used as a surrogate marker
for risk of adult disease, and special attention should be
directed toward modification of other cardiovascular risk
factors in individuals of LBW.
Reprint requests to Valerie A. Luyckx, Renal Division, MRB 4,
Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115.
E-mail: vluyckx@partners.org
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